Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Eur J Cardiothorac Surg. 2012 Sep;42(3):542-9. doi: 10.1093/ejcts/ezs096. Epub 2012 Feb 26.
Donor organ shortage remains to be the major limitation in lung transplantation, and donation after circulatory death (DCD) might represent one way to alleviate this problem. DCD was introduced to our institution in 2007 and has been a part of our clinical routine since then. Here, we present the mid-term results of lung transplantation from DCD in a single institution and compare the outcomes with the lung recipient cohort receiving lungs from donation after brain death (DBD).
Since initiation of the DCD programme in March 2007, of the 157 lung transplantations performed, 26 (16.5%) were retrieved from DCD donors, with 25 double- and 1 single-lung transplants being performed. Results were compared with standard DBD transplantations. Analyses included, amongst others, donor characteristics, survival, prevalence of primary graft dysfunction, acute rejection, lung function tests during follow-up, onset of bronchiolitis obliterans syndrome (BOS) as well as duration of mechanical ventilation, hospital and intensive care unit length of stay.
While there was no significant difference between lung function, BOS and survival between the two groups, lungs from DCD donors had a higher PaO(2) (median; interquartile range) 498.3 (451.5; 525) vs. DBD 442.5 (371.25; 502) kPa before retrieval (P = 0.009). There was also a longer total ischaemic time in the DCD vs. DBD group: 320 min (298.75; 393.25) vs. 285.5 min (240; 373) (P = 0.025). All other parameters were comparable.
Medium-term results after lung transplantation with organs procured after circulatory death are comparable with those obtained after standard lung transplantation. Therefore, DCD could be used to significantly increase the donor pool.
供体器官短缺仍然是肺移植的主要限制因素,而心跳停止后捐献(DCD)可能是缓解这一问题的一种方法。DCD 于 2007 年引入我们机构,并从那时起成为我们临床常规的一部分。在这里,我们报告了单一机构中 DCD 供体肺移植的中期结果,并将结果与接受脑死亡后捐献(DBD)供体肺的肺受体队列进行了比较。
自 2007 年 3 月启动 DCD 计划以来,在进行的 157 例肺移植中,有 26 例(16.5%)来自 DCD 供体,其中 25 例为双肺移植,1 例为单肺移植。结果与标准 DBD 移植进行了比较。分析包括供体特征、存活率、原发性移植物功能障碍、急性排斥反应、随访期间的肺功能检查、闭塞性细支气管炎综合征(BOS)的发生以及机械通气、住院和重症监护病房的持续时间。
虽然两组之间的肺功能、BOS 和存活率没有显著差异,但 DCD 供体的 PaO2(中位数;四分位距)更高,为 498.3(451.5;525)kPa,而 DBD 为 442.5(371.25;502)kPa,在采集前(P=0.009)。DCD 组的总缺血时间也较长:320min(298.75;393.25)比 DBD 组的 285.5min(240;373)(P=0.025)。所有其他参数均相似。
使用循环死亡后获取的器官进行肺移植的中期结果与标准肺移植获得的结果相当。因此,DCD 可用于显著增加供体库。